Exact Mass: 463.19862100000006

Exact Mass Matches: 463.19862100000006

Found 500 metabolites which its exact mass value is equals to given mass value 463.19862100000006, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-Hydroxynonenal glutathione

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(2S,3S,5R)-5-hydroxy-2-pentyloxolan-3-yl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C19H33N3O8S (463.19882580000007)

4-Hydroxynonenal glutathione (4-HNE-GSH) is the conjugated product of 4-hydroxy-2-nonenal with glutathione that is synthesized from a reaction catalyzed by glutathione transferases (GSTs). 4-Hydroxy-2-nonenal (4-HNE) is a major lipid peroxidation end product that is known to be highly toxic and very stable. It has been implicated in the pathogenesis and progression of a multitude of human diseases (e.g. cataractogenesis, diabetes, atherosclerosis, osteoporosis, Alzheimers disease, Parkinsons disease, multiple schlerosis, cancer, etc.) (PMID: 23848536). The primary mechanism of 4-HNE detoxification is via its conjugation to glutathione (PMID: 12892994).

Tafenoquine

N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine

C24H28F3N3O3 (463.2082654000001)

Lys Ser Asp Asp

(2S)-2-[(2S)-3-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]butanedioic acid

C17H29N5O10 (463.19143340000005)

Ala Ser Glu Ala Ser

C17H29N5O10 (463.19143340000005)

Ser Asp Ser Gly Val

C17H29N5O10 (463.19143340000005)

Asp Ser Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]hexanamido]butanedioic acid

C17H29N5O10 (463.19143340000005)

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C18H33N5O7S (463.2100588)

(4S)-4-{[(1S)-1-[(carboxymethyl)carbamoyl]-3-(methylsulfanyl)propyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C18H33N5O7S (463.2100588)

Trp Met Gln

C21H29N5O5S1 (463.18893040000006)

Lys Gly Glu Met

(4S)-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-4-{2-[(2S)-2,6-diaminohexanamido]acetamido}butanoic acid

C18H33N5O7S (463.2100588)

Lys Gly Met Glu

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-4-(methylsulfanyl)butanamido]pentanedioic acid

C18H33N5O7S (463.2100588)

Met Trp Gln

C21H29N5O5S1 (463.18893040000006)

Lys Met Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]propanamido]butanedioic acid

C18H33N5O7S (463.2100588)

Lys Met Asp Ala

(3S)-3-{[(1S)-1-carboxyethyl]carbamoyl}-3-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C18H33N5O7S (463.2100588)

Lys Met Glu Gly

(4S)-4-[(carboxymethyl)carbamoyl]-4-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]butanoic acid

C18H33N5O7S (463.2100588)

Lys Met Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]acetamido}pentanedioic acid

C18H33N5O7S (463.2100588)

Cys Trp Arg

C20H29N7O4S1 (463.20016340000006)

2-[(2S)-4-carbamoyl-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]acetic acid

C21H29N5O7 (463.2066884)

(3S)-3-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C16H29N7O9 (463.2026664)

Trp Cys Arg

C20H29N7O4S1 (463.20016340000006)

Trp Gln Met

C21H29N5O5S1 (463.18893040000006)

Mozavaptan hydrochloride

C27H30ClN3O2 (463.202643)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

Tafenoquine

C20H33NO9S (463.18759280000006)

ST 22:5;O3;Tau

C24H33NO6S (463.2028478000001)

SM1-71

C24H26ClN7O (463.18872560000005)

SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines[1][2][3].

Takeda103A

C24H23F2N7O (463.19320519999997)

Takeda103A is a potent inhibitor of GRK2. G protein-coupled receptors (GPCRs) are central to many physiological processes. Takeda103A has the potential for the research of heart failure[1].

(10s)-14-hydroxy-10-{[(2-hydroxyphenyl)methyl](methyl)amino}-3,4,5-trimethoxytricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-13-one

C27H29NO6 (463.19947740000003)